Barcelona, Spain

Marta Princep

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Ferrer Internacional, S.a.. Active years: 2011.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marta Princep: Innovator in Pharmaceutical Chemistry

Introduction

Marta Princep is a notable inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the brain. Her work is essential for advancing treatments for various diseases.

Latest Patents

Marta holds a patent for her invention titled "N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto." This patent describes compounds that exhibit a specific affinity for the GABA receptor, making them useful in the treatment and prevention of diseases modulated by the α- and β-GABA receptors. The compounds are defined by a specific formula, where R, R, and R are detailed in the claims.

Career Highlights

Throughout her career, Marta has worked with prominent companies in the pharmaceutical industry, including Ferrer Internacional, S.A. and Nicox S.A. Her experience in these organizations has allowed her to develop her innovative ideas into practical applications.

Collaborations

Marta has collaborated with several professionals in her field, including Antonio Guglietta and Albert Palomer. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Marta Princep is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. Her innovative compounds and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…